Skip to main content
Figure 1 | Experimental Hematology & Oncology

Figure 1

From: Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment

Figure 1

The cytotoxic assessment of BCT-100 on T-ALL blasts, hTertMSCs and hMSCs showed a dose-dependent response for T-ALL blasts but not MSCs. (a) CCRF-CEM, (b) Jurkat, (c) MOLT-4, (d) hTertMSCs and (e) hMSCs were treated with PBS (control) or different doses of BCT-100 (0.15625, 0.3125, 0.625, 1.25, 2.5 and 5 U/ml) for 48 hours, then subjected to XTT analysis. Values of cells viabilities were the representative results derived from 3 consistent experiments with error bars showing standard deviation. ***: p < 0.005 compared to control (0 U/ml).

Back to article page